- Bristol-Myers Squibb08.Dec 2016
-Strong product portfolio
-Competent new President of U.S.
-Endless amounts of unnecessary internal presentations & process that doesn't help patients, healthcare providers or payers
-Positions itself as a nimble biotech company but it couldn't be further from the truth. Either embrace current identity or make meaningful changes
-Look the other way mentality has led to non-compliance to certain rules/regulations